In response to a Request for Information (RFI), ASN recently submitted comments to the National Institutes of Health (NIH) with input from the ASN Diversity, Equity, and Inclusion Committee, the ASN Health Care Justice Committee, and the ASN Policy and Advocacy Committee.
In response to a Request for Information (RFI), ASN recently submitted comments to the National Institutes of Health (NIH) with input from the ASN Diversity, Equity, and Inclusion Committee, the ASN Health Care Justice Committee, and the ASN Policy and Advocacy Committee.
Titled Inviting Comments and Suggestions to Advance and Strengthen Racial Equity, Diversity, and Inclusion in the Biomedical Research Workforce and Advance Health Disparities and Health Equity Research , the RFI invited feedback on the approaches NIH can take to "advance racial equity, diversity, and inclusion within all facets of the biomedical research workforce, and expand research to eliminate or lessen health disparities and inequities."
As kidney disease disproportionately affects those that are disenfranchised, ASN advocates tirelessly for efforts to reduce health disparities and to develop a medical research and physician workforce that reflects the patient population it serves. Ensuring a diverse workforce that is representative of the 37,000,000 Americans living with kidney disease will generate world-class research and innovation leading to the development of better diagnosis, treatment, and preventative care.
ASN is pleased to see NIH address systemic challenges and barriers affecting the NIH workforce and NIH-supported biomedical community as these efforts will have a significant impact on improving the nation's kidney health.